These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17296830)

  • 1. What causes multiple sclerosis to worsen?
    Phillips JT
    Arch Neurol; 2007 Feb; 64(2):167-8. PubMed ID: 17296830
    [No Abstract]   [Full Text] [Related]  

  • 2. Visualizing the cause of gray matter atrophy in multiple sclerosis.
    Richert ND; Kraft E; Stüve O
    Arch Neurol; 2009 Feb; 66(2):159-60. PubMed ID: 19204151
    [No Abstract]   [Full Text] [Related]  

  • 3. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
    Sepulcre J; Goñi J; Masdeu JC; Bejarano B; Vélez de Mendizábal N; Toledo JB; Villoslada P
    Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis.
    Gout O
    Neurology; 2008 Jul; 71(1):69; author reply 69. PubMed ID: 18591511
    [No Abstract]   [Full Text] [Related]  

  • 5. Measuring brain atrophy in multiple sclerosis.
    De Stefano N; Battaglini M; Smith SM
    J Neuroimaging; 2007 Apr; 17 Suppl 1():10S-15S. PubMed ID: 17425728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis.
    Villoslada P; Sepulcre J; Toledo J; Bejarano B
    Neurology; 2008 Nov; 71(21):1747; author reply 1747-8. PubMed ID: 19015496
    [No Abstract]   [Full Text] [Related]  

  • 7. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E; Lee JC; Nakamura K; Rudick RA
    Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis.
    Gordon-Lipkin E; Chodkowski B; Reich DS; Smith SA; Pulicken M; Balcer LJ; Frohman EM; Cutter G; Calabresi PA
    Neurology; 2007 Oct; 69(16):1603-9. PubMed ID: 17938370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate of brain atrophy in benign vs early multiple sclerosis.
    Gauthier SA; Berger AM; Liptak Z; Duan Y; Egorova S; Buckle GJ; Glanz BI; Khoury SJ; Bakshi R; Weiner HL; Guttmann CR
    Arch Neurol; 2009 Feb; 66(2):234-7. PubMed ID: 19204160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain atrophy assessment in multiple sclerosis: importance and limitations.
    Giorgio A; Battaglini M; Smith SM; De Stefano N
    Neuroimaging Clin N Am; 2008 Nov; 18(4):675-86, xi. PubMed ID: 19068408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging.
    Chard D; Miller D
    J Neurol Sci; 2009 Jul; 282(1-2):5-11. PubMed ID: 19201002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle atrophy associated with multiple sclerosis: a benign condition or the onset of amyotrophic lateral sclerosis?
    Allen JA; Stein R; Baker RA; Royden Jones H
    J Clin Neurosci; 2008 Jun; 15(6):706-8. PubMed ID: 18395451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gray matter involvement in multiple sclerosis.
    Pirko I; Lucchinetti CF; Sriram S; Bakshi R
    Neurology; 2007 Feb; 68(9):634-42. PubMed ID: 17325269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid IgM index correlates with cranial MRI lesion load in patients with multiple sclerosis.
    Jongen PJ; Lycklama a Nijeholt G; Lamers KJ; Doesburg WH; Barkhof F; Lemmens WA; Klasen IS; Hommes OR
    Eur Neurol; 2007; 58(2):90-5. PubMed ID: 17570915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Starting early: MRI evidence of gray matter atrophy in children with multiple sclerosis.
    Banwell BL; Sled JG
    Neurology; 2008 Mar; 70(13 Pt 2):1065-6. PubMed ID: 18362266
    [No Abstract]   [Full Text] [Related]  

  • 16. Brain atrophy as an outcome measure for multiple sclerosis clinical trials: a "no-brainer"?
    Rudick RA; Fisher E
    Neurology; 2009 Feb; 72(7):586-7. PubMed ID: 19221291
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple sclerosis: is there neurodegeneration independent from inflammation?
    Lassmann H
    J Neurol Sci; 2007 Aug; 259(1-2):3-6. PubMed ID: 17367814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seizures in multiple sclerosis.
    Koch M; Uyttenboogaart M; Polman S; De Keyser J
    Epilepsia; 2008 Jun; 49(6):948-53. PubMed ID: 18336559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI to predict severe tissue damage in inflammatory lesions in animal models of multiple sclerosis.
    Brochet B; Dousset V; Deloire M; Boiziau C; Petry KG
    Brain; 2008 Mar; 131(Pt 3):e92. PubMed ID: 17965047
    [No Abstract]   [Full Text] [Related]  

  • 20. Regional brain atrophy development is related to specific aspects of clinical dysfunction in multiple sclerosis.
    Jasperse B; Vrenken H; Sanz-Arigita E; de Groot V; Smith SM; Polman CH; Barkhof F
    Neuroimage; 2007 Nov; 38(3):529-37. PubMed ID: 17889567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.